What is Your Infliximab Adherence Rate?

I started thinking about this question after a recent study (DS Vitale, et al. JPGN 2015; 61: 408-10) examined adherence at a single pediatric center (2010-2012). Adherence indicated “those who attended >80% of scheduled infusions.” Key findings:

  • 91.4% adherence rate of patients (n=151 with >4 infusions)
  • Adherent patients (n=138) attended an average of 98% of their infusions. Nonadherent patients attended, on average, 76% of their infusions.
  • The study provided some preliminary evidence that there was greater acute care use in nonadherent patients.
  • There were no demographic features that could predict adherence pattern.

My take: One of the key advantages of infusion therapy is improved and documented adherence.  Infusions also provide opportunities to assess patient in a scheduled manner. This study shows that subsets of patients with scheduled infusions have suboptimal adherence  — another target for quality improvement!

Atlanta Botanical Gardens, Bruce Munro Exhibit

Atlanta Botanical Gardens, Bruce Munro Exhibit


2 thoughts on “What is Your Infliximab Adherence Rate?

  1. Pingback: Gold Medal Winner: Infliximab (anti-TNF competition) | gutsandgrowth

  2. Pingback: February Briefs | gutsandgrowth

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.